Heinz Feldmann
Overview
Explore the profile of Heinz Feldmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
475
Citations
21011
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mihalakakos E, Ssempijja V, Ribeiro R, Molina-Paris C, Katushabe G, Nalwadda J, et al.
Emerg Microbes Infect
. 2025 Feb;
14(1):2465315.
PMID: 39945753
Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne disease endemic to many regions of Africa, the Middle East, Southeast Asia and the Balkans. Caused by the CCHF virus (CCHFV), CCHF has...
2.
Rosenke K, Giffin A, Griffin A, Kaiser F, Altynova E, Mukesh R, et al.
Nature
. 2025 Jan;
PMID: 39814072
Since early 2022, highly pathogenic avian influenza (HPAI) H5N1 virus infections have been reported in wild aquatic birds and poultry throughout the USA with spillover into several mammalian species. In...
3.
Hawman D, Tipih T, Hodge E, Stone E, Warner N, McCarthy N, et al.
Nat Commun
. 2025 Jan;
16(1):655.
PMID: 39809744
The ongoing circulation of influenza A H5N1 in the United States has raised concerns of a pandemic caused by highly pathogenic avian influenza. Although the United States has stockpiled and...
4.
Leventhal S, Shaia C, Rao D, Lewis M, Meade-White K, Erasmus J, et al.
NPJ Vaccines
. 2024 Dec;
9(1):249.
PMID: 39702459
Spread by Hyalomma genus ticks, Crimean-Congo hemorrhagic fever virus (CCHFV) causes a severe hemorrhagic disease endemic throughout Southern and Eastern Europe, Asia, and Africa. To date, there are no widely...
5.
Andrade V, Cashman K, Rosenke K, Wilkinson E, Josleyn N, Lynn G, et al.
Commun Med (Lond)
. 2024 Nov;
4(1):253.
PMID: 39609515
Background: We have previously developed a DNA-based vaccine, INO-4500, encoding the Lassa lineage IV glycoprotein precursor. INO-4500, when delivered with electroporation, elicited humoral and cellular responses, and conferred 100% protection...
6.
Leventhal S, Bisom T, Clift D, Rao D, Meade-White K, Shaia C, et al.
Nat Commun
. 2024 Oct;
15(1):9236.
PMID: 39455551
Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a negative-sense RNA virus spread by Hyalomma genus ticks across Europe, Asia, and Africa. CCHF disease begins as a non-specific febrile illness which may...
7.
Marzi A, Feldmann H
NPJ Vaccines
. 2024 Oct;
9(1):186.
PMID: 39394249
Nowadays, filovirus vaccine development may be seen as a paradigm for our response capabilities to emerging and re-emerging infectious diseases. Specifically, the West African Ebola virus disease (EVD) epidemic accelerated...
8.
Warner N, Archer J, Park S, Singh G, McFadden K, Kimura T, et al.
Sci Transl Med
. 2024 Aug;
16(759):eadi1625.
PMID: 39110777
The recent emergence and rapid response to severe acute respiratory syndrome coronavirus 2 was enabled by prototype pathogen and vaccine platform approaches, driven by the preemptive application of RNA vaccine...
9.
Zhou S, Long N, Rosenke K, Jarvis M, Feldmann H, Swanstrom R
J Infect Dis
. 2024 Jul;
230(6):1380-1383.
PMID: 38973065
We investigated the mutation profiles of severe acute respiratory syndrome coronavirus 2 in samples collected from a molnupiravir and nirmatrelvir/ritonavir combination therapy in macaques. We found that molnupiravir induced several...
10.
Moore K, Ostrowsky J, Mehr A, Johnson R, Ulrich A, Moua N, et al.
Lancet Infect Dis
. 2024 Jul;
24(11):e696-e706.
PMID: 38964363
In 2016, WHO designated Lassa fever a priority disease for epidemic preparedness as part of the WHO Blueprint for Action to Prevent Epidemics. One aspect of preparedness is to promote...